- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 1/26 - Electrophoresis
Patent holdings for IPC class C07K 1/26
Total number of patents in this class: 128
10-year publication summary
|
3
|
12
|
9
|
8
|
9
|
7
|
10
|
7
|
4
|
6
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| ProteinSimple | 89 |
11 |
| Bio-Rad Laboratories, Inc. | 1613 |
9 |
| Regeneron Pharmaceuticals, Inc. | 4246 |
6 |
| Enquyst Technologies Inc. | 11 |
5 |
| Life Technologies Corporation | 3286 |
4 |
| Kashiv Biosciences, LLC | 85 |
4 |
| The Regents of the University of California | 19868 |
3 |
| ARKRAY, Inc. | 874 |
3 |
| University of Notre Dame du Lac | 565 |
3 |
| The Johns Hopkins University | 5659 |
2 |
| Agency for Science, Technology and Research | 3604 |
2 |
| Terumo Kabushiki Kaisha | 5522 |
2 |
| GE Healthcare Bio-Sciences AB | 542 |
2 |
| Momenta Pharmaceuticals, Inc. | 290 |
2 |
| Nabsys 2.0 LLC | 25 |
2 |
| Temple University of the Commonwealth System of Higher Education | 612 |
2 |
| Universal Bio Research Co., Ltd. | 129 |
2 |
| The University of British Columbia | 1499 |
2 |
| Memphasys Ltd | 12 |
2 |
| Healthcare Financial Solutions, LLC, AS Agent (successor - in - interest to General Electric Capital Corp., AS Agent) | 10 |
2 |
| Other owners | 58 |